Introducing Emerging Concepts in Pharmacotherapeutics
- PMID: 33027193
- DOI: 10.1097/FJC.0000000000000904
Introducing Emerging Concepts in Pharmacotherapeutics
Comment on
-
Role of Bempedoic Acid in Dyslipidemia Management.J Cardiovasc Pharmacol. 2020 Oct;76(4):376-388. doi: 10.1097/FJC.0000000000000887. J Cardiovasc Pharmacol. 2020. PMID: 32732494 Review.
References
-
- Board C, Kelly MS, Shapiro MD, et al. PCSK9 inhibitors in secondary prevention—an opportunity for personalized therapy. J Cardiovasc Pharmacol. 2020;75:410–420.
-
- Bonaventura A, Carbone S, Dixon DL, et al. Pharmacologic strategies to reduce cardiovascular disease in type 2 diabetes mellitus: focus on SGLT-2 inhibitors and GLP-1 receptor agonists. J Intern Med. 2019;286:16–31.
-
- Roth GA, Johnson C, Abajobir A, et al. Global, regional, and national burden of cardiovascular diseases for 10 causes, 1990 to 2015. J Am Coll Cardiol. 2017;70:1–25.
-
- Dixon DL, Van Tassell BW, Vecchié A, et al. Cardiovascular considerations in treating patients with coronavirus disease 2019 (COVID-19). J Cardiovasc Pharmacol. 2020;75:359–367.
-
- Abbate A, Toldo S, Marchetti C, et al. Interleukin-1 and the inflammasome as therapeutic targets in cardiovascular disease. Circ Res. 2020;126:1260–1280.
Publication types
LinkOut - more resources
Full Text Sources